AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 19 filers reported holding AN2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,783 | -87.5% | 2,785 | -93.4% | 0.00% | – |
| Q2 2023 | $359,058 | -20.1% | 42,242 | -7.2% | 0.00% | – |
| Q1 2023 | $449,401 | +14.2% | 45,532 | +10.2% | 0.00% | – |
| Q4 2022 | $393,637 | -43.7% | 41,305 | +2.7% | 0.00% | – |
| Q3 2022 | $699,000 | +123.3% | 40,233 | -0.2% | 0.00% | – |
| Q2 2022 | $313,000 | +2135.7% | 40,331 | +4457.2% | 0.00% | – |
| Q1 2022 | $14,000 | – | 885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,773,517 | $37,244,613 | 0.84% |
| Monashee Investment Management LLC | 247,467 | $2,442,499 | 0.67% |
| BVF INC/IL | 1,563,963 | $15,436,315 | 0.56% |
| Avidity Partners Management LP | 723,200 | $7,137,984 | 0.24% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 52,500 | $518,175 | 0.01% |
| Alyeska Investment Group, L.P. | 48,426 | $477,965 | 0.00% |
| Citadel Advisors | 1,337,159 | $13,197,759 | 0.00% |
| Private Advisor Group, LLC | 22,008 | $217,219 | 0.00% |
| ETF MANAGERS GROUP, LLC | 6,742 | $66,544 | 0.00% |
| CITIGROUP INC | 134,473 | $1,327,249 | 0.00% |